Bonus BioGroup Ltd. (TLV:BONS)
Israel · Delayed Price · Currency is ILS · Price in ILA 20.40
-0.50 (-2.39%)
Aug 28, 2026, 1:44 PM IDT
Bonus BioGroup Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.44 | 0.23 | 6.86 | 12.94 | 53.62 | 79.55 |
Short-Term Investments | - | - | - | 13.04 | - | - |
Cash & Short-Term Investments | 0.44 | 0.23 | 6.86 | 25.98 | 53.62 | 79.55 |
Cash Growth | -63.32% | -96.68% | -73.59% | -51.56% | -32.59% | 394.53% |
Other Receivables | 1.27 | 0.62 | 0.09 | 0.25 | 0.51 | 1.16 |
Receivables | 1.27 | 0.62 | 0.09 | 0.25 | 0.51 | 1.16 |
Prepaid Expenses | - | 0.9 | 0.24 | 0.21 | 0.31 | 0.3 |
Total Current Assets | 1.71 | 1.75 | 7.19 | 26.44 | 54.43 | 81 |
Property, Plant & Equipment | 12.07 | 13.31 | 15.83 | 18.05 | 19.77 | 14.96 |
Long-Term Investments | - | - | - | - | - | 7.9 |
Other Intangible Assets | - | - | 0.01 | 0.02 | 0.04 | - |
Other Long-Term Assets | 0.38 | 0.38 | 0.38 | 0.37 | 0.37 | 0.46 |
Total Assets | 14.16 | 15.44 | 23.41 | 44.89 | 74.61 | 104.32 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.43 | 1.84 | 1.01 | 1.41 | 1.95 | 3.99 |
Accrued Expenses | - | 2.22 | 2 | 2.21 | 2.98 | 2.43 |
Current Portion of Leases | 1.85 | 1.79 | 1.66 | 1.48 | 1.35 | 1.23 |
Other Current Liabilities | 10.03 | 8.15 | 3.25 | 0.81 | 1.34 | 1.12 |
Total Current Liabilities | 16.31 | 13.99 | 7.92 | 5.91 | 7.62 | 8.77 |
Long-Term Leases | 6.33 | 7.11 | 8.53 | 9.67 | 10.6 | 11.12 |
Total Liabilities | 22.64 | 21.11 | 16.45 | 15.58 | 18.22 | 19.89 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 308.68 | 306.47 | 303.32 | 302.66 | 300.79 | 296.52 |
Retained Earnings | -374.14 | -362.09 | -337.6 | -309.78 | -281.25 | -242.55 |
Comprehensive Income & Other | 56.98 | 49.96 | 41.25 | 36.42 | 36.85 | 30.45 |
Shareholders' Equity | -8.48 | -5.66 | 6.96 | 29.31 | 56.39 | 84.43 |
Total Liabilities & Equity | 14.16 | 15.44 | 23.41 | 44.89 | 74.61 | 104.32 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.18 | 8.9 | 10.19 | 11.16 | 11.95 | 12.35 |
Net Cash (Debt) | -7.74 | -8.67 | -3.33 | 14.82 | 41.67 | 67.2 |
Net Cash Growth | - | - | - | -64.44% | -37.99% | 514.71% |
Net Cash Per Share | - | -0.01 | -0.00 | 0.01 | 0.04 | 0.06 |
Filing Date Shares Outstanding | - | 1,168 | 1,168 | 1,168 | 1,168 | 1,154 |
Total Common Shares Outstanding | - | 1,168 | 1,168 | 1,168 | 1,168 | 1,154 |
Working Capital | -14.6 | -12.24 | -0.73 | 20.53 | 46.81 | 72.23 |
Book Value Per Share | - | -0.00 | 0.01 | 0.03 | 0.05 | 0.07 |
Tangible Book Value | -8.48 | -5.66 | 6.95 | 29.28 | 56.35 | 84.43 |
Tangible Book Value Per Share | - | -0.00 | 0.01 | 0.03 | 0.05 | 0.07 |
Machinery | - | 3.68 | 4.35 | 4.25 | 4.05 | 0.8 |
Leasehold Improvements | - | 8.24 | 8.45 | 8.44 | 8.25 | 4.25 |